The Asia Pacific Cell Therapy Market is projected to grow significantly, with an estimated size of USD 824.6 million in 2024, forecasted to reach USD 2.77 billion by 2030, reflecting a CAGR of 22.49% from 2025 to 2030. Key drivers include advances in regenerative medicine, increased funding for cell-based research, and a focus on precision medicine. https://www.grandviewresearch.com/industry-analysis/asia-pacific-cell-therapy-market